Clover Biotech stated that currently, the flu vaccine produced by Guoguang Biotech can be administered in community health service centers in most provinces including Zhejiang, Shanghai, Jiangsu, Anhui, Shandong, Henan, Sichuan, Shaanxi, and Hunan. It hopes to provide better protection for more susceptible populations before the flu season arrives. In 2024, we will continue to improve our commercial strategic layout, expand the accessibility of Guoguang Biotech's flu vaccine, and strive to bring high-quality and safe vaccines with international processes to a wider range of people. Clover Biotech has introduced Guoguang Biotech's quadrivalent seasonal flu vaccine. Clover Biotech claims to be the only vaccine manufacturing company in Asia to have obtained dual GMP certification from the US FDA and the EU EMA. The quadrivalent seasonal flu vaccine from Guoguang Biotech has undergone multiple quality inspections and has strict quality control. It is also overall safe with a low incidence of adverse reactions, making it suitable for people aged three and above.